(Q71102143)
Statements
Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma? (English)
Covens A
Boucher S
Roche K
Macdonald M
Pettitt D
Jolain B
Souetre E
scientific article published on 01 May 1996